Harrow Health, Inc. (HROW)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$26.37
-2.08%
Mkt Cap $1.08B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (15 analysts)
$66.50
Range $45.00 – $88.00
Implied Upside
+152.2%
Consensus $66.50 vs current $26.37